JLab Hear OTC vs Nuheara IQBuds Max

The JLab Hear OTC is a budget-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.5/5 in our lab testing. At $100, it represents one of the most affordable entry points into the OTC hearing aid market, ranking #36 of 65 devices in its category. This visible-in-ear device delivers a distinctive performance profile with clear strengths and weaknesses. Its standout feature is excellent music streaming quality, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect stable performance without whistling during daily activities. These results suggest JLab leveraged its audio expertise from consumer earbuds in developing this product. However, speech clarity presents challenges. Speech in quiet scored 2.1/5 (0.67 points below category average), while speech in noise scored 1.0/5 (0.46 points below average). Own-voice comfort also measured low at 1.8/5. These limitations are significant for users prioritizing conversation clarity, which is typically the primary reason people seek hearing aids. The JLab Hear OTC is best suited for budget-conscious consumers who value music and media streaming alongside basic amplification, rather than those needing maximum speech intelligibility. Features include rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Buyers seeking stronger speech performance in this price range may want to compare options like the higher-scoring Elehear Beyond or Apple AirPods Pro 2.

The Nuheara IQBuds Max is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.3/5 in our lab testing. Priced at $499, this visible-in-ear device from 2021 ranks #46 of 65 OTC hearing aids tested, placing it in the top 69% of its category. The standout feature of the IQBuds Max is its exceptional music streaming performance, scoring 4.3/5—a strong result that sits 2.38 points above the category average. For users who prioritize audio entertainment alongside hearing assistance, this device delivers notably better streaming fidelity than most OTC alternatives. However, speech performance presents a mixed picture. Speech in quiet scores 2.0/5, falling 0.78 points below the category average. Speech in noise is essentially at par with competitors at 1.5/5, which is above average for the category but low in absolute terms. Own voice comfort also trails the category average by 0.31 points with a score of 2.2/5. Feedback handling scores a solid 3.4/5 in absolute terms, though this falls 1.14 points below the category average. The IQBuds Max is best suited for users who value music and audio streaming quality over speech clarity, particularly those seeking an affordable entry point into amplification. Competing devices in this price range—including the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5)—offer stronger overall sound performance for similar investment.